AI assistant
Zealand Pharma Director's Dealing 2022
3391_rpt_2022-05-25_e629d928-7597-4d05-9f38-9abb47bb5540.pdf
Director's Dealing
Open in viewerOpens in your device viewer
Template for notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
| 1. | Details of the person discharging managerial responsibilities/person closely associated | |||
|---|---|---|---|---|
| a) | Name | Christina S. Bredal | ||
| 2. | Reason for the notification | |||
| a) | Position/status | Senior Vice President, Head of People & Organization | ||
| b) | Initial notification/Amend ment |
Initial notification | ||
| 3. | tion monitor | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auc | ||
| a) | Name | Zealand Pharma A/S, CVR-no. 20045078 |
||
| b) | LEI1 | 549300ITBB1ULBL4CZ12 | ||
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||
| a) | Description of the financial instrument, type of instru ment |
Warrants | ||
| Identification code | DK0060257814 | |||
| b) | Nature of the transaction | Grant of Warrants |
||
| c) | Price(s) and volume(s) | Price(s) DKK 0 |
Volume(s) 29,261 |
|
| d) | Aggregated information - Aggregated volume - Price |
DKK 0 | ||
| e) | Date of the transaction | 25 May 2022 |
||
| f) | Place of the transaction | Outside trading venue |